Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 1.000 | |
4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.524 | |
3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.521 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.507 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.504 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.501 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.501 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.496 | |
3lqf | NAD | Galactitol dehydrogenase | / | 0.496 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.496 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.495 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.494 | |
3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.494 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.492 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.492 | |
3cxw | 7CP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.491 | |
3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.491 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.490 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.489 | |
2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.486 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.486 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.486 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.485 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.484 | |
4ux9 | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.484 | |
1e3e | NAI | Alcohol dehydrogenase 4 | 1.1.1.1 | 0.483 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.483 | |
4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.483 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.483 | |
2xj2 | 985 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.482 | |
3hyo | ADP | Pyridoxal kinase | / | 0.482 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
3t8o | ATP | Rhodopsin kinase | / | 0.481 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.478 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.478 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.477 | |
2q5g | 1FA | Peroxisome proliferator-activated receptor delta | / | 0.477 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.477 | |
3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.477 | |
4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.476 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.475 | |
2wyv | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.475 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.475 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.474 | |
2aaz | CB3 | Thymidylate synthase | 2.1.1.45 | 0.474 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.474 | |
5jla | NAD | Putative short-chain dehydrogenase/reductase | / | 0.474 | |
2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.473 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.473 | |
4bzo | 676 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.473 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.472 | |
4kio | G5K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.472 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
5a3c | NAD | SIR2 family protein | / | 0.471 | |
3gbu | ATP | Uncharacterized sugar kinase PH1459 | 2.7.1 | 0.470 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.470 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
4gb9 | 0WR | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.469 | |
1h66 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.468 | |
2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.468 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.468 | |
3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.468 | |
1yb5 | NAP | Quinone oxidoreductase | 1.6.5.5 | 0.467 | |
4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.467 | |
4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.467 | |
4q71 | FAD | Bifunctional protein PutA | / | 0.467 | |
1d4a | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.466 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.466 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.466 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.466 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
3ic9 | FAD | Putative dihydrolipoamide dehydrogenase | / | 0.465 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.465 | |
4bzn | UGX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.465 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.464 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
3umo | ATP | ATP-dependent 6-phosphofructokinase isozyme 2 | 2.7.1.11 | 0.464 | |
4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.464 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
4zs2 | FLU | Alpha-ketoglutarate-dependent dioxygenase FTO | / | 0.464 | |
3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.463 | |
4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.463 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.463 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
2hck | QUE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.462 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
2w06 | FRV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
2y4g | TIR | TamL | / | 0.461 | |
3t2z | FAD | Sulfide-quinone reductase | / | 0.461 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.461 | |
4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.461 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.461 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
1h69 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.460 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.460 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.460 | |
3dhe | AND | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.460 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
3nie | ANP | Mitogen-activated protein kinase | / | 0.460 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.460 | |
5ap7 | SVE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.460 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.459 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.459 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
4hjf | C2E | GGDEF family protein | / | 0.459 | |
4i6a | HMG | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.88 | 0.459 | |
1h0w | 207 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.458 | |
3c4x | ATP | Rhodopsin kinase | / | 0.458 | |
3etd | NDP | Glutamate dehydrogenase 1, mitochondrial | 1.4.1.3 | 0.458 | |
4jnk | ZHK | L-lactate dehydrogenase A chain | 1.1.1.27 | 0.458 | |
4yry | FAD | Glutamate synthase, beta subunit | / | 0.458 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.457 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.457 | |
2c3q | GTX | Glutathione S-transferase theta-1 | 2.5.1.18 | 0.457 | |
2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
3w2e | NAD | NADH-cytochrome b5 reductase 3 | 1.6.2.2 | 0.457 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.457 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.457 | |
4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.457 | |
4g7g | VFV | Lanosterol 14-alpha-demethylase | / | 0.457 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.457 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.456 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
3flk | NAI | Tartrate dehydrogenase/decarboxylase | 1.1.1.93 | 0.456 | |
3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.456 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.456 | |
3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.456 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
4l7f | 1V5 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.456 | |
4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.456 | |
4wsq | KSA | AP2-associated protein kinase 1 | 2.7.11.1 | 0.456 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.455 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.455 | |
2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
2g5c | NAD | Prephenate dehydrogenase | / | 0.455 | |
2j9m | PY8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
2nq8 | ZID | Enoyl-ACP reductase | / | 0.455 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.455 | |
3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.455 | |
4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.455 | |
4q72 | FAD | Bifunctional protein PutA | / | 0.455 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.455 | |
1rfv | ADP | Pyridoxal kinase | 2.7.1.35 | 0.454 | |
1xe5 | 5FE | Plasmepsin-2 | 3.4.23.39 | 0.454 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
2xrw | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.454 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.454 | |
3qxp | X64 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
4amb | DUD | Putative glycosyl transferase | / | 0.454 | |
4ewn | 0VR | Imidazole glycerol phosphate synthase subunit HisF | 4.1.3 | 0.454 | |
1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.453 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.453 | |
1uu9 | BI3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
2e9v | 85A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
2znp | K55 | Peroxisome proliferator-activated receptor delta | / | 0.453 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.453 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.453 | |
1pnv | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.452 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.452 | |
3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.452 | |
3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
4a6b | QG8 | Gag-Pol polyprotein | 3.4.23.16 | 0.452 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
5a4k | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.452 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.452 | |
2jkk | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.451 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
2zdt | 46C | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.451 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.451 | |
4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.451 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.451 | |
4hyh | 1AM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
4ivb | 1J5 | Tyrosine-protein kinase JAK1 | / | 0.451 | |
1bws | NDP | GDP-L-fucose synthase | / | 0.450 | |
1unl | RRC | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.450 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.450 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.450 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.450 | |
3gw9 | VNI | Lanosterol 14-alpha-demethylase | / | 0.450 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
3q43 | D66 | M1 family aminopeptidase | 3.4.11 | 0.450 | |
3w0s | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.450 | |
4g3j | VNT | Lanosterol 14-alpha-demethylase | / | 0.450 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.450 | |
4i8z | G08 | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
1rfu | ADP | Pyridoxal kinase | 2.7.1.35 | 0.449 | |
1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.449 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.449 | |
2y3r | TIR | TamL | / | 0.449 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.449 | |
4anw | O92 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.449 | |
5eai | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.449 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.448 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
3o0g | 3O0 | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.448 | |
3r7y | Z04 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.448 | |
4fg8 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.448 | |
1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
1pd9 | CO4 | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.447 | |
1t7i | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
1wlv | COA | Phenylacetic acid degradation protein PaaI | / | 0.447 | |
2bpv | 1IN | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
2c1b | CQP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.447 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
2xs0 | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.447 | |
2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.447 | |
3lit | E15 | Protease | / | 0.447 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3qql | X03 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.447 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.447 | |
4fv4 | EK7 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.447 | |
4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
1dxo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.446 | |
1mjb | ACO | Histone acetyltransferase ESA1 | / | 0.446 | |
1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
2f7x | 4EA | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.446 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
2x7h | PFN | Prostaglandin reductase 3 | 1 | 0.446 | |
3b6z | CO7 | Enoyl reductase LovC | 1 | 0.446 | |
3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.446 | |
3ibq | ATP | Pyridoxal kinase | / | 0.446 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.446 | |
3qru | X19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3toh | 079 | Gag-Pol polyprotein | 2.7.7.49 | 0.446 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.446 | |
4ijp | 1EH | Serine/threonine-protein kinase PRP4 homolog | 2.7.11.1 | 0.446 | |
4w9w | YDJ | BMP-2-inducible protein kinase | 2.7.11.1 | 0.446 | |
5a3b | APR | SIR2 family protein | / | 0.446 | |
1c70 | L75 | Protease | / | 0.445 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
2c27 | ACO | Mycothiol acetyltransferase | 2.3.1.189 | 0.445 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.445 | |
2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.445 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
3i2l | 2NC | Protease | / | 0.445 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
3rai | X85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
4jin | 1L7 | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.445 | |
4q73 | FAD | Bifunctional protein PutA | / | 0.445 | |
5hbr | COA | Acyl-CoA synthetase (NDP forming) | / | 0.445 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
1men | GAR | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.444 | |
1nyt | NAP | Shikimate dehydrogenase (NADP(+)) | / | 0.444 | |
1tvo | FRZ | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
2bpw | 1IN | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
2cgv | 3B3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
2xc3 | RT8 | Steroid C26-monooxygenase | 1.14.13.141 | 0.444 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3s1d | ZIR | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.444 | |
3syi | FAD | Sulfide-quinone reductase | / | 0.444 | |
3t2y | FAD | Sulfide-quinone reductase | / | 0.444 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.444 | |
3zm4 | 22T | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.444 | |
4a6c | QG9 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.444 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
5cvf | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
5hs1 | VOR | Lanosterol 14-alpha demethylase | / | 0.444 | |
1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.443 | |
1mj9 | COA | Histone acetyltransferase ESA1 | / | 0.443 | |
2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
2npn | SAM | Putative cobalamin synthesis related protein | / | 0.443 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2y3s | TIR | TamL | / | 0.443 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.443 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.443 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.443 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.443 | |
4y93 | 746 | Tyrosine-protein kinase | / | 0.443 | |
4yr9 | NAD | L-threonine 3-dehydrogenase, mitochondrial | 1.1.1.103 | 0.443 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.443 | |
2ejv | NAD | L-threonine 3-dehydrogenase | / | 0.442 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.442 | |
2ou2 | ACO | Histone acetyltransferase KAT5 | / | 0.442 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.442 | |
3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3inm | NDP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.442 | |
3m42 | HGF | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.442 | |
3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.442 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.442 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
4fw8 | NAI | 3-oxoacyl-(Acyl-carrier-protein) reductase | / | 0.442 | |
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.442 | |
4jbi | NDP | Alcohol dehydrogenase (Zinc) | / | 0.442 | |
4wuo | NAD | 3-isopropylmalate dehydrogenase | 1.1.1.85 | 0.442 | |
1fy7 | COA | Histone acetyltransferase ESA1 | / | 0.441 | |
1xe6 | 5FP | Plasmepsin-2 | 3.4.23.39 | 0.441 | |
2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
2jds | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
2ktd | PUC | Prostaglandin-H2 D-isomerase | 5.3.99.2 | 0.441 | |
2nnh | REA | Cytochrome P450 2C8 | / | 0.441 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
3ozd | 4CT | S-methyl-5'-thioadenosine phosphorylase | / | 0.441 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
3qwf | NAP | 17beta-hydroxysteroid dehydrogenase | / | 0.441 | |
3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.441 | |
1ha3 | MAU | Elongation factor Tu-A | / | 0.440 | |
2c6d | ANP | Aurora kinase A | 2.7.11.1 | 0.440 | |
2g22 | 6IG | Renin | 3.4.23.15 | 0.440 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.440 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2zdu | 446 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.440 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.440 | |
3oev | 3OE | Proteasome subunit beta type-5 | 3.4.25.1 | 0.440 | |
3oev | 3OE | Proteasome subunit beta type-6 | 3.4.25.1 | 0.440 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.440 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.440 | |
4jik | 1KO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
4pkl | 1GH | Uncharacterized protein | / | 0.440 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.440 | |
4z61 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.440 | |
5c41 | ACP | Ribokinase | / | 0.440 |